Linearis Ventures
Overview
Linearis Ventures is a venture capital firm based in Quebec City that invests in early-stage life sciences and AI-powered healthcare companies, operating with a tandem laboratory to support drug discovery, diagnostics, and patient monitoring.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Scopia Surgical | Sep 2026 | Pre Seed | Lead |
| Feldan Therapeutics | Feb 2025 | Strategic | Co-investor |
| Noetik | Aug 2024 | Series A | Co-investor |
| Zilia | May 2025 | Debt | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Linearis Ventures based?
Linearis Ventures is headquartered in Canada.
When was Linearis Ventures founded?
Linearis Ventures was founded in 2023.
How many portfolio companies does Linearis Ventures have?
Linearis Ventures has 4 portfolio companies in Caplight's dataset.
What are some companies in Linearis Ventures's portfolio?
Portfolio companies visible on Caplight include Scopia Surgical, Feldan Therapeutics, Noetik, Zilia.
What was Linearis Ventures's most recent investment shown here?
Linearis Ventures's most recent investment in this portfolio sample was in Scopia Surgical in 2026.
What sectors does Linearis Ventures focus on?
Linearis Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Linearis Ventures focus on?
Stage focus information for Linearis Ventures is not publicly available.
What is Linearis Ventures's AUM?
Linearis Ventures's assets under management are estimated between $50.0M and $50.0M.